crysvita
kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - lääkkeet luusairauksien hoitoon - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.
alendronat ratiopharm 70 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - sodium alendronate trihydrate - tabletti, kalvopäällysteinen - 70 mg - alendronaatti
sodium iodide i-131 0.6 - 3.7 mbq kapseli diagnostiikkaan
mallinckrodt medical b.v. - natrii iodidum (131i) - kapseli diagnostiikkaan - 0.6 - 3.7 mbq - natriumjodidi(131i)
sodium iodide i-131 37 - 7400 mbq kapseli terapiaan
curium netherlands b.v. - 131i-sodiumiodide - kapseli terapiaan - 37 - 7400 mbq - natriumjodidi(131i)
motifene dual 75 mg depotkapseli
stada nordic aps - diclofenac sodium - depotkapseli - 75 mg - diklofenaakki
ibusal 600 mg tabletti, kalvopäällysteinen
orion corporation - ibuprofen - tabletti, kalvopäällysteinen - 600 mg - ibuprofeeni
ibusal 800 mg tabletti, kalvopäällysteinen
orion corporation - ibuprofen - tabletti, kalvopäällysteinen - 800 mg - ibuprofeeni
ibutabs 400 mg tabletti, kalvopäällysteinen
orion corporation - ibuprofen - tabletti, kalvopäällysteinen - 400 mg - ibuprofeeni
ibumetin 600 mg tabletti, kalvopäällysteinen
orifarm healthcare a/s - ibuprofen - tabletti, kalvopäällysteinen - 600 mg - ibuprofeeni
naprometin 500 mg tabletti
atnahs pharma netherlands b.v. - naproxen - tabletti - 500 mg - naprokseeni